Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2970739 | The Journal of Heart and Lung Transplantation | 2012 | 8 Pages |
Abstract
Biopsy findings of AMR (pAMR 2 or higher) are common after pediatric HT. Like cellular rejection, biopsy grading of AMR seems important to delineate those at risk of adverse events. Our results suggest that pAMR 3 is associated with worse CV outcomes. Widespread surveillance for pAMR with a uniform grading system is an important next step to further validate these findings in the pediatric HT population.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Melanie D. MD, M. Elizabeth H. MD, Gregory L. PhD, Josef MD, Monica P. MD, Dylan V. MD, Aditya K. MD, Deborah MD, Rami MD, Kimberly M. MD, Abdallah G. MD,